NCT00129857View on ClinicalTrials.gov

Dexanabinol in Severe Traumatic Brain Injury

PHASE3CompletedINTERVENTIONAL

Enrollment

860

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

September 30, 2004

Conditions

Traumatic Brain Injury

Interventions

DRUG

Dexanabinol

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pharmos

INDUSTRY